Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

NCT05740943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Peking Union Medical College Hospital Beijin, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangzhou Twelfth People's Hospital Guangzhou, Guangdong, China
  • The Second Xiangya Hospital of Central South University Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

NCT02411448

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica Los Angeles, California, United States
  • St. Charles Health System Denver, Colorado, United States
  • The Gastroenterology Group, P.C. Honolulu, Hawaii, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

NCT05845671

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Outpatient CTRC Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

NCT06155279

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Humanitas Gavazzeni Bergamo, Italia/Bergamo, Italy
  • IFO - Istituto Tumori Regina Elena, Roma Roma, Italia/Roma, Italy
  • Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Centro di Riferimento Oncologico (CRO) IRCCS Aviano, Pordenone, Italy
View Trial Details
Active, Not Recruiting

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

NCT05651022

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +31 more
Locations
  • University of Southern California- Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

NCT02715284

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
View all 105 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

NCT05353257

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-Stage Small Cell Lung Cancer, +8 more
Locations
  • OPN-Glendale Arcadia, California, United States
  • OPN-Los Alamitos Los Alamitos, California, United States
  • Southern California Permanente Group Los Angeles, California, United States
  • Emad Ibrahim, MD, Inc Redlands, California, United States
View all 129 locations
View Trial Details

Related conditions